Lipoic acid as an inducer of phase II detoxification enzymes through activation of Nrf2-dependent gene expression

Lipoic Acid: Energy Production, Antioxidant Activity and Health Effects

Volumn , Issue , 2008, Pages 349-371

  Shay, Kate Petersen ^a   Shenvi, Swapna ^a   Hagen, Tory M ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955646477     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (87)

1. Banning, A., S. Deubel, D. Kluth, Z. Zhou, and R. Brigelius-Flohe. 2005. The GI-GPx gene is a target for Nrf2. Mol Cell Biol 25:4914-4923.
2. Bast, A. and G.R. Haenen. 1988. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta 963:558-561.
3. Bloom, D.A. and A.K. Jaiswal. 2003. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. JBiol Chem 278:44675-44682.
4. Breithaupt-Grogler, K., G. Niebch, E. Schneider, K. Erb, R. Hermann, H.H. Blume, B.S. Schug, and G.G. Belz. 1999. Dose-proportionality of oral thioctic acid-coincidence of assessments via pooled plasma and individual data. Eur J Pharm Sci 8:57-65.
5. Busse, E., G. Zimmer, B. Schopohl, and B. Kornhuber. 1992. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 42:829-831.
6. Bustamante, J., J.K. Lodge, L. Marcocci, H.J. Tritschler, L. Packer, and B.H. Rihn. 1998. Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med 24:1023-1039.
7. Chan, K., X.D. Han, and Y.W. Kan. 2001. An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen. Proc Natl Acad Sci USA 98:4611-1616.
8. Chanas, S.A., Q. Jiang, M. McMahon, G.K. McWalter, L.I. McLellan, C.R. Elcombe, C.J. Henderson, C.R. Wolf, G.J. Moffat, K. Itoh, M. Yamamoto, and J.D. Hayes. 2002. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J 365:405-116.
9. Chen, Z.H., Y. Saito, Y. Yoshida, A. Sekine, N. Noguchi, and E. Niki. 2005. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 280:41921-11927.
10. Cho, K.J., H. Moini, H.K. Shon, A.S. Chung, and L. Packer. 2003. Alpha-lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes. Biochem Pharmacol 66:849-858.
11. Cremer, D.R., R. Rabeler, A. Roberts, and B. Lynch. 2006. Long-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study. Regul Toxicol Pharmacol 46:193-201.
12. Cullinan, S.B., J.D. Gordan, J. Jin, J.W. Harper, and J.A. Diehl. 2004. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 24:8477-8486.
13. Cullinan, S.B., D. Zhang, M. Hannink, E. Arvisais, R.J. Kaufman, and J.A. Diehl. 2003. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 23:7198-7209.
14. Dinkova-Kostova, A.T., W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, and P. Talalay. 2002. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99:11908-11913.
15. Eggler, A.L., G. Liu, J.M. Pezzuto, R.B. van Breemen, and A.D. Mesecar. 2005. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc Natl Acad Sci USA 102:10070-10075.
16. Enomoto, A., K. Itoh, E. Nagayoshi, J. Haruta, T. Kimura, T. O'Connor, T. Harada, and M. Yamamoto. 2001. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci 59:169-177.
17. Evans, J.L., C.J. Heymann, I.D. Goldfine, and L.A. Gavin. 2002. Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid. Endocr Pract 8:29-35.
18. Favreau, L.V. and C.B. Pickett. 1991. Transcriptional regulation of the rat NAD(P)H: quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J Biol Chem 266:4556-4561.
19. Hagen, T.M., V. Vinarsky, C.M. Wehr, and B.N. Ames. 2000. (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. Antioxid Redox Signal 2:473-483.
20. Han, D., G. Handelman, L. Marcocci, C.K. Sen, S. Roy, H. Kobuchi, H.J. Tritschler, L. Flohe, and L. Packer. 1997. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 6:321-338.
21. Harrison, E.H. and D.B. McCormick. 1974. The metabolism of dl-(1,6-14C)lipoic acid in the rat. Arch Biochem Biophys 160:514-522.
22. He, X., M.G. Chen, G.X. Lin, and Q. Ma. 2006. Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 X Keap1 X Cul3 complex and recruiting Nrf2 X Maf to the antioxidant response element enhancer. J Biol Chem 281:23620-23631.
23. Huang, H.C., T. Nguyen, and C.B. Pickett. 2002. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277:42769-42774.
24. Huang, H.C., T. Nguyen, and C.B. Pickett. 2000. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci USA 97:12475-12480.
25. Itoh, K., T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236:313-322.
26. Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, and M. Yamamoto. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13:76-86.
27. Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, T. O'Connor, and M. Yamamoto. 2003. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8:379-391.
28. Jain, A.K. and A.K. Jaiswal. 2006. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J Biol Chem 281:12132-12142.
29. Kang, M.I., A. Kobayashi, N. Wakabayashi, S.G. Kim, and M. Yamamoto. 2004. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci U S A 101:2046-2051.
30. Karapetian, R.N., A.G. Evstafieva, I.S. Abaeva, N.V. Chichkova, G.S. Filonov, Y.P. Rubtsov, E.A. Sukhacheva, S.V. Melnikov, U. Schneider, E.E. Wanker, and A.B. Vartapetian. 2005. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: Implications for expression of oxidative stress-protecting genes. Mol Cell Biol 25:1089-1099.
31. Kim, Y.C., Y. Yamaguchi, N. Kondo, H. Masutani, and J. Yodoi. 2003. Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 22:1860-1865.
32. Kobayashi, A., M.I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, K. Igarashi, and M. Yamamoto. 2004. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24:7130-7139.
33. Kobayashi, A., M.I. Kang, Y. Watai, K.I. Tong, T. Shibata, K. Uchida, and M. Yamamoto. 2006. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 26:221-229.
34. Kobayashi, M., K. Itoh, T. Suzuki, H. Osanai, K. Nishikawa, Y. Katoh, Y. Takagi, and M. Yamamoto. 2002. Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system. Genes Cells 7:807-820.
35. Kwak, M.K., T.W. Kensler, and R.A. Casero, Jr. 2003. Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: Effect of the polyamine metabolite acrolein. Biochem Biophys Res Commun 305:662-670.
36. Kwak, M.K., N. Wakabayashi, J.L. Greenlaw, M. Yamamoto, and T.W. Kensler. 2003. Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 23:8786-8794.
37. Kwak, M.K., N. Wakabayashi, K. Itoh, H. Motohashi, M. Yamamoto, and T.W. Kensler. 2003. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. JBiol Chem 278:8135-8145.
38. Lee, T.D., H. Yang, J. Whang, and S.C. Lu. 2005. Cloning and characterization of the human glutathione synthetase 5'-flanking region. Biochem J 390:521-528.
39. Li, Y. and A.K. Jaiswal. 1992. Regulation of human NAD(P)H:quinone oxidore-ductase gene. Role of AP1 binding site contained within human antioxidant response element. J Biol Chem 267:15097-15104.
40. Louhelainen, M., S. Merasto, P. Finckenberg, R. Lapatto, Z.J. Cheng, and E.M. Mervaala. 2006. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. J Hypertens 24:947-956.
41. Maitra, I., E. Serbinova, H.J. Tritschler, and L. Packer. 1996. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats. Biochem Biophys Res Commun 221:422-429.
42. Martin, D., A.I. Rojo, M. Salinas, R. Diaz, G. Gallardo, J. Alam, C.M. De Galarreta, and A. Cuadrado. 2004. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem 279:8919-8929.
43. McMahon, M., K. Itoh, M. Yamamoto, S.A. Chanas, C.J. Henderson, L.I. McLellan, C.R. Wolf, C. Cavin, and J.D. Hayes. 2001. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61:3299-3307.
44. McMahon, M., K. Itoh, M. Yamamoto, and J.D. Hayes. 2003. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278:21592-21600.
45. Moinova, H.R. and R.T. Mulcahy. 1998. An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. J Biol Chem 273:14683-14689.
46. Moinova, H.R. and R.T. Mulcahy. 1999. Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. Biochem Biophys Res Commun 261:661-668.
47. Mulcahy, R.T. and J.J. Gipp. 1995. Identification of a putative antioxidant response element in the 5'-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Biophys Res Commun 209:227-233.
48. Muller, C., F. Dunschede, E. Koch, A.M. Vollmar, and A.K. Kiemer. 2003. Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol 285:G769-G778.
49. Nguyen, T., P.J. Sherratt, H.C. Huang, C.S. Yang, and C.B. Pickett. 2003. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 278:4536-4541.
50. Nguyen, T., P.J. Sherratt, P. Nioi, C.S. Yang, and C.B. Pickett. 2005. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J Biol Chem 280: 32485-32492.
51. Nioi, P., M. McMahon, K. Itoh, M. Yamamoto, and J.D. Hayes. 2003. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P) H:quinone oxidoreductase 1 gene: Reassessment of the ARE consensus sequence. Biochem J 374:337-348.
52. Nishinaka, T. and C. Yabe-Nishimura. 2005. Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene. J Pharmacol Sci 97:43-51.
53. Ogborne, R.M., S.A. Rushworth, and M.A. O'Connell. 2005. Alpha-lipoic acid-induced heme oxygenase-1 expression is mediated by nuclear factor erythroid 2-related factor 2 and p38 mitogen-activated protein kinase in human monocytic cells. Arterioscler Thromb Vasc Biol 25:2100-2105.
54. Okawa, H., H. Motohashi, A. Kobayashi, H. Aburatani, T.W. Kensler, and M. Yamamoto. 2006. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun 339:79-88.
55. Prestera, T., P. Talalay, J. Alam, Y.I. Ahn, P.J. Lee, and A.M. Choi. 1995. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electro-philes and antioxidants: Regulation by upstream antioxidant-responsive elements (ARE). Mol Med 1:827-837.
56. Primiano, T., T.W. Kensler, P. Kuppusamy, J.L. Zweier, and T.R. Sutter. 1996. Induction of hepatic heme oxygenase-1 and ferritin in rats by cancer chemopreventive dithiolethiones. Carcinogenesis 17:2291-2296.
57. Primiano, T., Y. Li, T.W. Kensler, M.A. Trush, and T.R. Sutter. 1998. Identification of dithiolethione-inducible gene-1 as a leukotriene B4 12-hydroxydehydrogenase: Implications for chemoprevention. Carcinogenesis 19:999-1005.
58. Ramos-Gomez, M., M.K. Kwak, P.M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T.W. Kensler. 2001. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 98:3410-3415.
59. Reljanovic, M., G. Reichel, K. Rett, M. Lobisch, K. Schuette, W. Moller, H.J. Tritschler, and H. Mehnert. 1999. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). alpha lipoic acid in diabetic neuropathy. Free Radic Res 31:171-179.
60. Ruhnau, K.J., H.P. Meissner, J.R. Finn, M. Reljanovic, M. Lobisch, K. Schutte, D. Nehrdich, H.J. Tritschler, H. Mehnert, and D. Ziegler. 1999. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 16:1040-1043.
61. Rushmore, T.H., R.G. King, K.E. Paulson, and C.B. Pickett. 1990. Regulation of glutathione S-transferase Ya subunit gene expression: Identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc Natl Acad Sci U S A 87:3826-3830.
62. Rushworth, S.A., R.M. Ogborne, C.A. Charalambos, and M.A. O'Connell. 2006. Role of protein kinase C delta in curcumin-induced antioxidant response elementmediated gene expression in human monocytes. Biochem Biophys Res Commun 341:1007-1016.
63. Sakurai, A., M. Nishimoto, S. Himeno, N. Imura, M. Tsujimoto, M. Kunimoto, and S. Hara. 2005. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: Role of NF-E2-related factor-2. J Cell Physiol 203:529-537.
64. Salazar, M., A.I. Rojo, D. Velasco, R.M. de Sagarra, and A. Cuadrado. 2006. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 281:14841-14851.
65. Shelby, M.K. and C.D. Klaassen. 2006. Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways. Drug Metab Dispos 34:1772-1778.
66. Slitt, A.L., N.J. Cherrington, M.Z. Dieter, L.M. Aleksunes, G.L. Scheffer, W. Huang, D.D. Moore, and C.D. Klaassen. 2006. trans-Stilbene oxide induces expression of genes involved in metabolism and transport in mouse liver via CAR and Nrf2 transcription factors. Mol Pharmacol 69:1554-1563.
67. Suh, J.H., S.V. Shenvi, B.M. Dixon, H. Liu, A.K. Jaiswal, R.M. Liu, and T.M. Hagen. 2004. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 101:3381-3386.
68. Suh, J.H., H. Wang, R.M. Liu, J. Liu, and T.M. Hagen. 2004. (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: Evidence for increased cysteine requirement for GSH synthesis. Arch Biochem Biophys 423:126-135.
69. Tanito, M., H. Masutani, Y.C. Kim, M. Nishikawa, A. Ohira, and J. Yodoi. 2005. Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest Ophthalmol Vis Sci 46:979-987.
70. Teichert, J., J. Kern, H.J. Tritschler, H. Ulrich, and R. Preiss. 1998. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther 36:625-628.
71. Thimmulappa, R.K., K.H. Mai, S. Srisuma, T.W. Kensler, M. Yamamoto, and S. Biswal. 2002. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62:5196-5203.
72. Velichkova, M. and T. Hasson. 2005. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol Cell Biol 25:4501-4513.
73. Wakabayashi, N., A.T. Dinkova-Kostova, W.D. Holtzclaw, M.I. Kang, A. Kobayashi, M. Yamamoto, T.W. Kensler, and P. Talalay. 2004. Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 101:2040-2045.
74. Wakabayashi, N., K. Itoh, J. Wakabayashi, H. Motohashi, S. Noda, S. Takahashi, S. Imakado, T. Kotsuji, F. Otsuka, D.R. Roop, T. Harada, J.D. Engel, and M. Yamamoto. 2003. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 35:238-245.
75. Wasserman, W.W. and W.E. Fahl. 1997. Functional antioxidant responsive elements. Proc Natl Acad Sci USA 94:5361-5366.
76. Wild, A.C., J.J. Gipp, and T. Mulcahy. 1998. Overlapping antioxidant response element and PMA response element sequences mediate basal and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase catalytic subunit gene. Biochem J 332 (Pt 2):373-381.
77. Wild, A.C., H.R. Moinova, and R.T. Mulcahy. 1999. Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 274:33627-33636.
78. Xu, C., X. Yuan, Z. Pan, G. Shen, J.H. Kim, S. Yu, T.O. Khor, W. Li, J. Ma, and A.N. Kong. 2006. Mechanism of action of isothiocyanates: The induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphory-lation and nuclear translocation of Nrf2. Mol Cancer Ther 5:1918-1926.
79. Yaworsky, K., R. Somwar, T. Ramlal, H.J. Tritschler, and A. Klip. 2000. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43:294-303.
80. Zhang, D.D., S.C. Lo, J.V. Cross, D.J. Templeton, and M. Hannink. 2004. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 24:10941-10953.
81. Zhang, H., H. Liu, D.A. Dickinson, R.M. Liu, E.M. Postlethwait, Y. Laperche, and H.J. Forman. 2006. Gamma-glutamyl transpeptidase is induced by 4-hydroxynonenal viaEpRE/Nrf2signalinginratepithelialtypeIIcells. FreeRadicBiolMed40:1281-1292.
82. Zhang, H., H. Liu, K.E. Iles, R.M. Liu, E.M. Postlethwait, Y. Laperche, and H.J. Forman. 2006. 4-Hydroxynonenal induces rat gamma-glutamyl transpeptidase through mitogen-activated protein kinase-mediated electrophile response element/ nuclear factor erythroid 2-related factor 2 signaling. Am J Respir Cell Mol Biol 34:174-181.
83. Zhang, L., G.Q. Xing, J.L. Barker, Y. Chang, D. Maric, W. Ma, B.S. Li, and D.R. Rubinow. 2001. Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signaling pathway. Neurosci Lett 312:125-128.
84. Ziegler, D. 2004. Thioctic acid for patients with symptomatic diabetic polyneuropathy: A critical review. Treat Endocrinol 3:173-189.
85. Ziegler, D., M. Hanefeld, K.J. Ruhnau, H. Hasche, M. Lobisch, K. Schutte, G. Kerum, and R. Malessa. 1999. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic acid in diabetic neuropathy. Diabetes Care 22:1296-1301.
86. Ziegler, D., M. Hanefeld, K.J. Ruhnau, H.P. Meissner, M. Lobisch, K. Schutte, and F.A. Gries. 1995. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38:1425-1433.
87. Zipper, L.M. and R.T. Mulcahy. 2002. The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J Biol Chem 277:36544-36552.